Floatz logo

(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE

Depression

University of WashingtonSmall moleculePhase 3Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
73/ 100

Competitive context

73 Active assets in the Depression cohort.

Asset / SponsorPhaseRating
S-Ketamine
Chinese PLA General Hospital
Phase 4BBB
Opc-34712
Dr. Albert Kar-Kin Chung
Phase 4BBB
LITHIUM, ELEMENTAL
Rakitzi, Stavroula
Phase 4BBB
Cipralex
Poznan University of Medical Sciences
Phase 4BBB
VENLOR
Janssen Research & Development, LLC
Phase 4BBB

View all 50 →

Same molecule, other indications

(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:

Pain, PostoperativeDormant
BBB
Indicative ·
78 / 100
View asset →
Anesthesia, LocalDormant
BBB
Indicative ·
76 / 100
View asset →
neuralgiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →